Xencor Share Holder Equity 2012-2025 | XNCR

Xencor share holder equity from 2012 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
Xencor Annual Share Holder Equity
(Millions of US $)
2024 $674
2023 $662
2022 $727
2021 $734
2020 $572
2019 $593
2018 $522
2017 $316
2016 $314
2015 $162
2014 $59
2013 $74
2012 $-20
2011 $-11
Xencor Quarterly Share Holder Equity
(Millions of US $)
2025-06-30 $620
2025-03-31 $640
2024-12-31 $674
2024-09-30 $706
2024-06-30 $549
2024-03-31 $600
2023-12-31 $662
2023-09-30 $669
2023-06-30 $679
2023-03-31 $684
2022-12-31 $727
2022-09-30 $723
2022-06-30 $742
2022-03-31 $763
2021-12-31 $734
2021-09-30 $619
2021-06-30 $647
2021-03-31 $584
2020-12-31 $572
2020-09-30 $568
2020-06-30 $571
2020-03-31 $593
2019-12-31 $593
2019-09-30 $610
2019-06-30 $608
2019-03-31 $610
2018-12-31 $522
2018-09-30 $532
2018-06-30 $519
2018-03-31 $538
2017-12-31 $316
2017-09-30 $291
2017-06-30 $301
2017-03-31 $304
2016-12-31 $314
2016-09-30 $202
2016-06-30 $209
2016-03-31 $159
2015-12-31 $162
2015-09-30 $153
2015-06-30 $162
2015-03-31 $169
2014-12-31 $59
2014-09-30 $60
2014-06-30 $66
2014-03-31 $70
2013-12-31 $74
2013-09-30 $5
2013-06-30 $0
2013-03-31 $0
2012-12-31
2012-09-30 $0
2011-12-31 $-11
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.557B $0.110B
Xencor Inc. is a clinical-stage biopharmaceutical company. It develops antibodies for the treatment of autoimmune diseases, asthma and allergic diseases, and cancer. Xencor Inc. is based in Monrovia, California.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $69.605B 26.77
Zoetis (ZTS) United States $67.506B 24.49
Daiichi Sankyo, - (DSNKY) Japan $48.761B 24.99
Takeda Pharmaceutical (TAK) Japan $48.238B 9.84
BeOne Medicines - (ONC) Switzerland $34.998B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.281B 0.00
Summit Therapeutics (SMMT) United States $19.529B 0.00
Merck (MKKGY) Germany $16.730B 10.88
Shionogi (SGIOY) Japan $14.921B 14.95
United Therapeutics (UTHR) United States $14.168B 12.26
Neurocrine Biosciences (NBIX) United States $13.205B 39.39
Orion OYJ (ORINY) Finland $11.245B 27.10
IPSEN (IPSEY) France $10.601B 0.00
Eisai (ESAIY) $9.193B 10.37
Madrigal Pharmaceuticals (MDGL) United States $8.691B 0.00
Corcept Therapeutics (CORT) United States $7.561B 63.50
Grifols, S.A (GRFS) Spain $7.274B 0.00
Ionis Pharmaceuticals (IONS) United States $6.922B 0.00
Stevanato Group S.p.A (STVN) Italy $6.841B 40.34
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.405B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.402B 18.55
Soleno Therapeutics (SLNO) United States $3.619B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.908B 13.82
NewAmsterdam Pharma (NAMS) Netherlands $2.861B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.801B 0.00
Hypermarcas (HYPMY) Brazil $2.597B 19.52
Catalyst Pharmaceuticals (CPRX) United States $2.476B 8.29
Centessa Pharmaceuticals (CNTA) United Kingdom $2.356B 0.00
Ocular Therapeutix (OCUL) United States $2.142B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.759B 0.00
Dyne Therapeutics (DYN) United States $1.754B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.609B 23.96
Guardian Pharmacy Services (GRDN) United States $1.571B 0.00
Harrow (HROW) United States $1.418B 0.00
Ardelyx (ARDX) United States $1.400B 0.00
ARS Pharmaceuticals (SPRY) United States $1.387B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.309B 0.00
Evotec AG (EVO) Germany $1.307B 0.00
Collegium Pharmaceutical (COLL) United States $1.203B 6.57
Xeris Biopharma Holdings (XERS) United States $1.188B 0.00
Enliven Therapeutics (ELVN) United States $1.170B 0.00
Cronos Group (CRON) Canada $0.969B 0.00
Akebia Therapeutics (AKBA) United States $0.825B 0.00
ProKidney (PROK) United States $0.743B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.719B 7.41
Amylyx Pharmaceuticals (AMLX) United States $0.712B 0.00
Theravance Biopharma (TBPH) United States $0.685B 56.71
KalVista Pharmaceuticals (KALV) United States $0.666B 0.00
Siga Technologies (SIGA) United States $0.639B 7.89
Elite Pharmaceuticals (ELTP) United States $0.615B 0.00
Relay Therapeutics (RLAY) United States $0.598B 0.00
Bioventus (BVS) United States $0.594B 14.36
Organogenesis (ORGO) United States $0.581B 0.00
Oruka Therapeutics (ORKA) United States $0.571B 0.00
Tourmaline Bio (TRML) United States $0.569B 0.00
USANA Health Sciences (USNA) United States $0.554B 11.36
Savara (SVRA) United States $0.527B 0.00
Nektar Therapeutics (NKTR) United States $0.522B 0.00
Zevra Therapeutics (ZVRA) United States $0.516B 0.00
Esperion Therapeutics (ESPR) United States $0.423B 0.00
Nanobiotix S.A (NBTX) France $0.422B 0.00
Aquestive Therapeutics (AQST) United States $0.417B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.351B 0.00
4D Molecular Therapeutics (FDMT) United States $0.340B 0.00
Aldeyra Therapeutics (ALDX) United States $0.326B 0.00
Larimar Therapeutics (LRMR) United States $0.323B 0.00
Altimmune (ALT) United States $0.314B 0.00
Nature's Sunshine Products (NATR) United States $0.290B 18.93
AleAnna (ANNA) United States $0.282B 0.00
Galectin Therapeutics (GALT) United States $0.250B 0.00
OmniAb (OABI) United States $0.247B 0.00
Lyell Immunopharma (LYEL) United States $0.209B 0.00
Aclaris Therapeutics (ACRS) United States $0.200B 0.00
Heron Therapeutics (HRTX) United States $0.199B 0.00
MediWound (MDWD) Israel $0.190B 0.00
Korro Bio (KRRO) United States $0.185B 0.00
China SXT Pharmaceuticals (SXTC) China $0.184B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.183B 28.25
Innate Pharma SA (IPHYF) France $0.173B 0.00
Lexeo Therapeutics (LXEO) United States $0.163B 0.00
Journey Medical (DERM) United States $0.163B 0.00
MEI Pharma (MEIP) United States $0.158B 0.00
Avita Medical (RCEL) United States $0.148B 0.00
Profound Medical (PROF) Canada $0.143B 0.00
Achieve Life Sciences (ACHV) Canada $0.136B 0.00
Inhibikase Therapeutics (IKT) United States $0.128B 0.00
Protara Therapeutics (TARA) United States $0.124B 0.00
Avalo Therapeutics (AVTX) United States $0.119B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Cassava Sciences (SAVA) United States $0.110B 0.00
Liminatus Pharma (LIMN) United States $0.103B 0.00
Cardiol Therapeutics (CRDL) Canada $0.102B 0.00
Dominari Holdings (DOMH) United States $0.100B 0.00
Champions Oncology (CSBR) United States $0.096B 21.78
Surrozen (SRZN) United States $0.095B 0.00
ESSA Pharma (EPIX) Canada $0.090B 0.00
VAXART, INC (VXRT) United States $0.083B 0.00
PMV Pharmaceuticals (PMVP) United States $0.082B 0.00
BioNxt Solutions (BNXTF) Canada $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.080B 0.00
Context Therapeutics (CNTX) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.078B 0.00
Pyxis Oncology (PYXS) United States $0.077B 0.00
Vivani Medical (VANI) United States $0.073B 0.00
Metagenomi (MGX) United States $0.072B 0.00
Nutriband (NTRB) United States $0.071B 0.00
Inotiv (NOTV) United States $0.066B 0.00
Gain Therapeutics (GANX) United States $0.064B 0.00
DURECT (DRRX) United States $0.059B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.058B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.058B 0.00
Wellgistics Health (WGRX) United States $0.057B 0.00
PolyPid (PYPD) Israel $0.056B 0.00
Rafael Holdings (RFL) United States $0.054B 0.00
Prelude Therapeutics (PRLD) United States $0.053B 0.00
Unicycive Therapeutics (UNCY) United States $0.052B 0.00
Fractyl Health (GUTS) United States $0.051B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Karyopharm Therapeutics (KPTI) United States $0.048B 0.00
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.048B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.046B 27.91
FibroGen (FGEN) United States $0.046B 0.00
Tempest Therapeutics (TPST) United States $0.045B 0.00
Acrivon Therapeutics (ACRV) United States $0.044B 0.00
Jupiter Neurosciences (JUNS) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.039B 0.00
Klotho Neurosciences (KLTO) United States $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Plus Therapeutics (PSTV) United States $0.032B 0.00
Mural Oncology (MURA) Ireland $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
CASI Pharmaceuticals (CASI) China $0.028B 0.00
Vivos Therapeutics (VVOS) United States $0.026B 0.00
Cosmos Health (COSM) United States $0.026B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.025B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Relmada Therapeutics (RLMD) United States $0.022B 0.00
Scienture Holdings (SCNX) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Incannex Healthcare (IXHL) Australia $0.012B 0.00
Carisma Therapeutics (CARM) United States $0.012B 0.00
Heatwurx (PCSA) United States $0.011B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
VYNE Therapeutics (VYNE) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
BioVie (BIVI) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.16
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.65
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00